Form 4: NHI Director Lilly Donohue Receives Restricted Stock Grant

National Health Investors director Lilly Donohue was granted 1,268 shares of common stock as a restricted award, vesting in March 2027.

Summary

• Lilly Donohue, a Director of National Health Investors Inc. (NHI), was granted 1,268 shares of common stock.
• The transaction occurred on March 3, 2026, and the shares were acquired at a price of $0, indicating a grant.
• These shares represent a restricted stock award that will vest in full on March 3, 2027.
• Vesting is contingent upon Ms. Donohue's continued service as a director through the vesting date.
• Following this transaction, Ms. Donohue beneficially owns 1,268 shares of common stock directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a slightly positive development, as it represents a routine compensation event that enhances director-shareholder alignment, though the transaction size is not significant enough to materially impact company valuation.

Positives

• The restricted stock grant aligns the director's financial interests with those of the shareholders, promoting long-term value creation.
• Equity compensation is a standard practice to attract and retain qualified board members.

Future Outlook

The future outlook for the granted shares is tied to the director's continued service through March 3, 2027, at which point the shares will fully vest.

Industry Context

StockSavvy.ai notes that providing equity compensation, such as restricted stock grants, to non-executive directors is a common practice across various industries, including healthcare REITs like National Health Investors. This method is widely used to incentivize directors to focus on the company's long-term performance and align their interests with those of shareholders.

Comparison to Industry Standards

• Equity compensation for directors, including restricted stock awards, is a standard practice in the U.S. market, comparable to compensation structures seen in other publicly traded REITs and healthcare companies.
• The vesting schedule tied to continued service is typical for such grants, ensuring retention and ongoing commitment from board members.

Stakeholder Impact

• Shareholders: The grant increases alignment between the director's interests and shareholder value, potentially leading to more shareholder-friendly decisions.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• Lilly Donohue's continued service as a director until March 3, 2027, for the restricted stock to fully vest.

Key Dates

Keywords

National Health Investors, NHI, Lilly Donohue, Director, Restricted Stock, Equity Grant, Insider Transaction, Form 4, Corporate Governance